The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

• Published in: The Journal of clinical investigation 2024-04, Vol.134 (8), p.1-13
• Main Authors: Gasca-Capote, Carmen, Lian, Xiaodong, Gao, Ce, Roseto, Isabelle C, Jiménez-León, María Reyes, Gladkov, Gregory, Camacho-Sojo, María Inés, Pérez-Gómez, Alberto, Gallego, Isabel, Lopez-Cortes, Luis E, Bachiller, Sara, Vitalle, Joana, Rafii-El-Idrissi Benhnia, Mohamed, Ostos, Francisco J, Collado-Romacho, Antonio R, Santos, Jesús, Palacios, Rosario, Gomez-Ayerbe, Cristina, Muñoz-Medina, Leopoldo, Ruiz-Sancho, Andrés, Frias, Mario, Rivero-Juarez, Antonio, Roca-Oporto, Cristina, Hidalgo-Tenorio, Carmen, Rull, Anna, Olalla, Julian, Lopez-Ruz, Miguel A, Vidal, Francesc, Viladés, Consuelo, Mastrangelo, Andrea, Cavassini, Matthias, Espinosa, Nuria, Perreau, Matthieu, Peraire, Joaquin, Rivero, Antonio, López-Cortes, Luis F, Lichterfeld, Mathias, Yu, Xu G, Ruiz-Mateos, Ezequiel
• Format: Article
• Language: English
• Subjects: Anti-Retroviral Agents - therapeutic use; Antiretroviral therapy; Antiviral agents; Comparative analysis; Control; Development and progression; Diagnosis; Drug therapy; Genes; Genetic aspects; Genomes; Heterochromatin; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV infection; HIV Infections - drug therapy; HIV-1 - genetics; Human immunodeficiency virus; Humans; Immunology; Leukocytes, Mononuclear; Measurement; Next-generation sequencing; Peripheral blood mononuclear cells; Phenotypes; Proviruses; Proviruses - genetics; Risk factors; Satellite DNA; Viremia; Zinc finger proteins
• ISSN: 1558-8238; 0021-9738; 1558-8238
• DOI: 10.1172/JCI174215

BACKGROUNDPersistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure.METHODSThe characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq).RESULTSPCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PCs and TCs. However, intact provirus levels were lower in PCs compared with TCs; indeed the intact/defective HIV-DNA ratio was significantly higher in TCs. Clonally expanded intact proviruses were found only in PCs and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TCs.CONCLUSIONSThese results suggest the need for, and can give guidance to, the design of future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART.FUNDINGInstituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057, PI18/01532, PI19/01127 and PI22/01796), Gilead Fellowships (GLD22/00147). NIH grants AI155171, AI116228, AI078799, HL134539, DA047034, MH134823, amfAR ARCHE and the Bill and Melinda Gates Foundation.